FILE PHOTO: Vials of coronavirus disease (COVID-19) vaccines of Pfizer-BioNTech and Moderna are seen in the town of Ricany near Prague, Czech Republic, February 25, 2021. REUTERS/David W Cerny/File Photo/File Photo/File Photo(Reuters) -People who got Johnson & Johnson Inc’s COVID-19 vaccine as a first shot had a stronger immune response when boosted with vaccines from
(Reuters) -The U.S. Centers for Disease Control and Prevention (CDC) on Friday backed a booster shot of the Pfizer/BioNTech COVID-19 vaccine for Americans aged 65 and older, adults with underlying medical conditions and adults in high-risk working and institutional settings. The decision by CDC Director Rochelle Walensky is aligned with the U.S. Food and Drug
Within the next few weeks, the U.S. Food and Drug Administration is expected to recommend a plan for immunocompromised Americans to get a COVID-19 booster shot, a senior government official familiar with the agency’s planning told ABC News on Thursday. The plan is expected by early September, if not sooner, the government official said. The
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok